воскресенье, 10 января 2016 г.

Barclays Increases Hologic, Inc. (HOLX) Price Target to $42.00

Barclays Increases Hologic, Inc. (HOLX) Price Target to $42.00


The firm currently has an "equal weight" rating on the stock. Barclays' price objective indicates a potential upside of 14.91% from the stock's previous close.



from Biotech News